| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels MK Madsen, PM Fisher, D Burmester, A Dyssegaard, DS Stenbæk, ... Neuropsychopharmacology 44 (7), 1328-1334, 2019 | 346 | 2019 |
| A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding MK Madsen, PMD Fisher, DS Stenbæk, S Kristiansen, D Burmester, ... European Neuropsychopharmacology 33, 71-80, 2020 | 136 | 2020 |
| Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans DS Stenbæk, MK Madsen, B Ozenne, S Kristiansen, D Burmester, ... Journal of Psychopharmacology 35 (4), 459-468, 2021 | 59 | 2021 |
| Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels MK Madsen, PM Fisher, D Burmester, A Dyssegaard, DS Stenbæk, ... Neuropsychopharmacology 44 (7), 1336, 2019 | 12 | 2019 |
| Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study DS Stenbæk, S Kristiansen, D Burmester, MK Madsen, VG Frokjaer, ... Human Brain Mapping 40 (7), 2117-2124, 2019 | 11 | 2019 |
| Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation DR Burmester, MK Madsen, A Szabo, SS Aripaka, DS Stenbæk, ... Comprehensive psychoneuroendocrinology 13, 100163, 2023 | 6 | 2023 |
| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology [Internet]. 2019; 44 (7): 1328–34 MK Madsen, PM Fisher, D Burmester, A Dyssegaard, DS Stenbæk, ... | 3 | |
| Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C] Cimbi-36 PET study in humans MK Madsen, D Burmester, DS Stenbæk, S Kristiansen, A Dyssegaard, ... European Neuropsychopharmacology 29, S304-S305, 2019 | 2 | 2019 |
| Dopaminerge lægemidler til behandling af depression D Burmester, CM von Buchwald, P Videbech Ugeskr Læger 183, V06210490, 2021 | | 2021 |
| Dopaminergic drugs in the treatment of depression D Burmester, CM von Buchwald, P Videbech Ugeskrift for Laeger 183 (47), V06210490-V06210490, 2021 | | 2021 |
| P. 188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality MK Madsen, PM Fisher, DS Stenbæk, S Kristiansen, D Burmester, ... European Neuropsychopharmacology 29, S144, 2019 | | 2019 |
| P. 839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels D Stenbæk, MK Madsen, B Ozenne, S Kristiansen, D Burmester, ... European Neuropsychopharmacology 29, S558, 2019 | | 2019 |
| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (vol 44, pg 1328, 2019) MK Madsen, PM Fisher, D Burmester, A Dyssegaard, DS Stenbaek, ... NEUROPSYCHOPHARMACOLOGY 44 (7), 1336-1337, 2019 | | 2019 |
| Comprehensive Psychoneuroendocrinology DR Burmester, MK Madsen, A Szabo, SS Aripaka, DS Stenbæk, ... | | |
| S304 Abstracts MK Madsen, D Burmester, DS Stenbæk, S Kristiansen, A Dyssegaard, ... Gen 69, 776-786, 0 | | |
Dea Siggaard StenbækVerified email at nru.dk
